Article
Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens.
Antiviral therapy - 1 Jan 2011
Bunupuradah Torsak, Ananworanich Jintanat, Chetchotisakd Ploenchan, Kantipong Pacharee, Jirajariyavej Supunnee, Sirivichayakul Sunee, Munsakul Warangkana, Prasithsirikul Wisit, Sungkanuparph Somnuek, Bowonwattanuwong Chureeratana, Klinbuayaem Virat, Petoumenos Kathy, Hirschel Bernard, Bhakeecheep Sorakij, Ruxrungtham Kiat
Abstract excerpt
BACKGROUND: We studied prevalence of etravirine (ETR) and rilpivirine (RPV) resistance in HIV-1 subtype CRF01_AE infection with first-line non-nucleoside reverse transcriptase inhibitor (NNRTI) failure. METHODS: A total of 225 adults failing two nucleoside reverse transcriptase inhibitors (NRTIs) plus 1 NNRTI in Thailand with HIV RNA>1,000 copies/ml were included. Genotypic resistance results and HIV-1 subtype...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
